Nan Fung Group Holdings LTD Pacific Biosciences Of California, Inc. Transaction History

Nan Fung Group Holdings LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.97 - $10.36 $822,863 - $1.43 Million	137,833 Added 100.86%	274,488 $2.69 Million
Q4 2022 Feb 13, 2023	SELL	$5.67 - $11.2 $46,408 - $91,672	-8,185 Reduced 5.65%	136,655 $1.12 Million
Q1 2022 May 13, 2022	SELL	$8.43 - $20.9 $226,935 - $562,628	-26,920 Reduced 15.67%	144,840 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $3.31 Million - $5.17 Million	171,760 New	171,760 $3.51 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Group Holdings LTD with notifications on news.